longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

SWS Medical

688410

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 23.00, below the reasonable range, cheaper than 99.36% of the time in the past 3 years, and the industry ranks 9/65, the industry Median 26.96.

23xP/E
¥9.52Stock price
¥0.41Earnings per share
23xP/E
Stock price¥9.52Earnings per share¥0.41

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
41.70x
Typical range
28.72x–54.69x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 26.96x
012243648

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 26.96x
0x30x60x90x120x150x
P/E ratio
Name/Symbol
300760SZMindray
25.53x1.70%¥200.80B
002223SZYUYUE MEDICAL
22.71x0.70%¥25.47B
300003SZLepu Medical
26.96x16.83%¥20.78B
002901SZDouble Medical
23.27x13.61%¥16.49B
603014SHWeigao Blood Purification
26.44x2.19%¥13.00B
300529SZJAFRON
23.15x18.12%¥12.15B
600587SHSHINVA
17.78x--¥7.57B
300206SZEdan
18.72x--¥6.61B
301367SZBMC
25.86x27.60%¥5.71B
688236SHChunli Medical
18.91x0.00%¥5.26B
300326SZKinetic Medical
19.92x--¥4.48B
688410SHSWS Medical
23.00x45.87%¥4.26B
688581SHAGS
19.05x79.57%¥4.07B
688580SHVISHEE
23.41x20.83%¥3.95B
301033SZMedprin
28.81x--¥3.53B
688358SHCHISON MEDICAL
26.49x17.31%¥3.07B
688314SHKontour Medical
29.31x--¥2.49B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.